Navigation Links
Biomarker for prostate cancer may be separated for treatment

Scientists at UCLA had been able to isolate a biomarker for prostate cancer cells do// that it will become easier to treat the disease.

The biomarker protein, which was hidden inside the cells, can now be moved to a different location from where it can go into the blood. This will make it possible for the medical professionals to treat the prostate cancer disease with both chemotherapy and immunotherapy, for better and more effective way to kill the cancerous cells.

The researchers had placed the prostate-specific membrane antigen (PSMA) at a new location for the immunotherapy that is carried by the blood, to reach the biomarker. This had been done by a chemotherapy agent, which destroys the microtubules.

Cancer of the prostate glands is one of the deadlier cancers that affect males mostly above 40 years of age. The new research may make the worst cases of prostate cancer treatable and curable as well. Using both chemotherapy and immunotherapy together may also benefit those patients in whom the cancer had spread from prostate gland to other parts of the body.

The research results are published in the current issue of the journal Molecular Cancer Therapeutics.

Reference: UCLA, News release, May 2005 , prostate cancer, biomarker, chemotherapy, immunotherapy, microtubules, cancerous cells
'"/>




Page: 1

Related medicine news :

1. Biomarkers May Indicate Alzheimers Disease
2. Biomarkers Could Prove Significant In Understanding Aging Process
3. IMP3 the Novel Biomarker for Metastatic Cancer
4. Biomarker Reduces Length of Antibiotic Treatment
5. Researchers Find Mix of Biomarkers Predicting Mortality
6. Biomarkers Predicting Mortality Found Using Statistical Technique
7. Biomarkers Found Harmful For Human Lupus
8. Researchers Find Two Biomarkers With Potential to Predict Breast Cancer Spread
9. Biomarkers Ability to Predict Heart Disease and Stroke is Limited
10. Uric Acid -Biomarker for Dementia
11. Probable Biomarkers for Squamous Cell Carcinoma
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2017)... ... April 29, 2017 , ... TransDark is a set of dynamic transitions ... the next without having to set a single keyframe in Final Cut Pro ... video production. , TransDark features dynamic transitions that momentarily splits the RGB layers of ...
(Date:4/28/2017)... ... April 28, 2017 , ... An April 24th article on Yahoo! Beauty discusses ... with the help of a weight loss surgery. The woman, declaring “I will not hate ... been left following her dramatic weight loss. Dr. Feiz & Associates notes that, while it ...
(Date:4/28/2017)... ... 2017 , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the ... ClearLungs Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength ... , Removal of the homeopathic element , Adding their ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio ... These lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most ... disconnect ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving ...
(Date:4/28/2017)... ... April 28, 2017 , ... From April 30 to May ... Medicine will host industry leaders for the annual spring Convention & Expo, called ... industry adapt to the issues currently affecting urgent care and on-demand healthcare. , ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology: